Clinical activity and benefit of irinotecan(CPT11) in patients with colorectal cancer tryly resistant to 5-fluorouracil (5-FU).

E van Cutsem; D Cunningham; W.W. ten Bokkel Huinink; C.J Punt; C.G Alexopoulos; L.Y. Dirix; M. Symann; G.H. Blijham; P Cholet; G Filet; M. van Groeningen; J.M Vannetzel; F Levi; G Panagos; C Unger; J Wils; C Cote; C Blanc; P Herait; H Bleiberg

Clinical activity and benefit of irinotecan(CPT11) in patients with colorectal cancer tryly resistant to 5-fluorouracil (5-FU).

Translated title of the contribution: Clinical activity and benefit of irinotecan(CPT11) in patients with colorectal cancer tryly resistant to 5-fluorouracil (5-FU).

E van Cutsem
, D Cunningham
, W.W. ten Bokkel Huinink
, C.J Punt
, C.G Alexopoulos
, L.Y. Dirix
, M. Symann
, G.H. Blijham
, P Cholet
, G Filet
, M. van Groeningen
, J.M Vannetzel
, F Levi
, G Panagos
, C Unger
, J Wils
, C Cote
, C Blanc
, P Herait
, H Bleiberg

Division Imaging & Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Clinical activity and benefit of irinotecan(CPT11) in patients with colorectal cancer tryly resistant to 5-fluorouracil (5-FU).
Original language	Undefined/Unknown
Pages (from-to)	54-59
Number of pages	6
Journal	European Journal of Cancer
Volume	35(1)
Publication status	Published - 1999

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Algemeen onderzoek
Internal medicine

Cite this

van Cutsem, E., Cunningham, D., ten Bokkel Huinink, W. W., Punt, C. J., Alexopoulos, C. G., Dirix, L. Y., Symann, M., Blijham, G. H., Cholet, P., Filet, G., van Groeningen, M., Vannetzel, J. M., Levi, F., Panagos, G., Unger, C., Wils, J., Cote, C., Blanc, C., Herait, P., & Bleiberg, H. (1999). Clinical activity and benefit of irinotecan(CPT11) in patients with colorectal cancer tryly resistant to 5-fluorouracil (5-FU). European Journal of Cancer, 35(1), 54-59.

@article{a11433be782942cd813ba0b7f3ed4c86,

title = "Clinical activity and benefit of irinotecan(CPT11) in patients with colorectal cancer tryly resistant to 5-fluorouracil (5-FU).",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Algemeen onderzoek, Internal medicine",

author = "\{van Cutsem\}, E and D Cunningham and \{ten Bokkel Huinink\}, W.W. and C.J Punt and C.G Alexopoulos and L.Y. Dirix and M. Symann and G.H. Blijham and P Cholet and G Filet and \{van Groeningen\}, M. and J.M Vannetzel and F Levi and G Panagos and C Unger and J Wils and C Cote and C Blanc and P Herait and H Bleiberg",

year = "1999",

language = "Undefined/Unknown",

volume = "35(1)",

pages = "54--59",

}

van Cutsem, E, Cunningham, D, ten Bokkel Huinink, WW, Punt, CJ, Alexopoulos, CG, Dirix, LY, Symann, M, Blijham, GH, Cholet, P, Filet, G, van Groeningen, M, Vannetzel, JM, Levi, F, Panagos, G, Unger, C, Wils, J, Cote, C, Blanc, C, Herait, P & Bleiberg, H 1999, 'Clinical activity and benefit of irinotecan(CPT11) in patients with colorectal cancer tryly resistant to 5-fluorouracil (5-FU).', European Journal of Cancer, vol. 35(1), pp. 54-59.

TY - JOUR

T1 - Clinical activity and benefit of irinotecan(CPT11) in patients with colorectal cancer tryly resistant to 5-fluorouracil (5-FU).

AU - van Cutsem, E

AU - Cunningham, D

AU - ten Bokkel Huinink, W.W.

AU - Punt, C.J

AU - Alexopoulos, C.G

AU - Dirix, L.Y.

AU - Symann, M.

AU - Blijham, G.H.

AU - Cholet, P

AU - Filet, G

AU - van Groeningen, M.

AU - Vannetzel, J.M

AU - Levi, F

AU - Panagos, G

AU - Unger, C

AU - Wils, J

AU - Cote, C

AU - Blanc, C

AU - Herait, P

AU - Bleiberg, H

PY - 1999

Y1 - 1999

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Algemeen onderzoek

KW - Internal medicine

M3 - Article

SN - 0959-8049

VL - 35(1)

SP - 54

EP - 59

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -